Business

BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, will participate virtually in a fireside chat at A.G.P.'s Healthcare Company Showcase. Fireside Chat Details: Time: 11:40 AM ETDate: Wednesday, May 20, 2026 Investors can register for the conference and view the fireside chat here. About BioCardia® BioCardia, Inc., headquartered in Sunnyvale, Cali

Biocardia, Inc.May 19, 20261
BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

About this update from Biocardia, Inc.

SUNNYVALE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc.  [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, will participate virtually in a fireside chat at A.G.P.'s Healthcare Company Showcase. Fireside Chat Details: Investors can register for the conference and view the fireside chat  here . About BioCardia ® BioCardia, Inc. , headquartered in Sunnyvale, California, is developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP ® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms for the treatment of heart disease. These therapies are enabled by its Helix™   biotherapeutic delivery and Morph ® vascular navigation product platforms. For more information visit:  www.BioCardia.com . CONTACT: Media Contact: Miranda Peto, Investor Relations Email: [email protected] Phone: 650-226-0120 Investor Contact: David McClung, Chief Financial Officer Email: [email protected] Phone: 650-226-0120

View stock analysis, news, and events for Biocardia, Inc.

BioCardia, Inc.pulmonary diseasesfireside chatA.G.P.'s Healthcare Company Showcase

More from Biocardia, Inc.

All Biocardia, Inc. news →